Wellington Pham received a Ph.D. degree in Medicinal and Biological Chemistry from the University of Toledo. His postdoctoral training focused on nuclear chemistry at the Crump Institute for Molecular Imaging, UCLA Medical School, followed by two postdoctoral trainings in cancer and neuro-imaging at the Center of Molecular Imaging Research and Martinos Center for Molecular Imaging, respectively, Harvard Medical School. Prior to joining the faculty at Vanderbilt School of Medicine in 2006, Dr. Pham was a faculty member at Harvard Medical School, where he pioneered the integration of fluorescence technology with nanotechnology for multimodal detection of cancer and Alzheimer’s disease. Currently, he is a tenured Associate Professor in the Department of Radiology and Radiological Sciences and holds joint appointments in the Departments of Biomedical Engineering and Vanderbilt Brain Institute. Dr. Pham was a member of the Editorial Board of Nanomedicine: Nanotechnology Biology and Medicine (2014-2016), American Association of Cancer Research-Chemistry in Cancer Research (2012- 2014), Journal of Molecular Biomarkers and Diagnosis (2011-present), Journal of Alzheimer’s Disease (2014-2016) and Precision Nanomedicine (2018-present). He served on several steering committees and conference organizers on molecular imaging and molecular probes, and a recipient of the Japanese Academy of Pharmaceutical Science and Technology Award (2010), and a distinguished investigator of the Academy for Radiology & Biomedical Imaging Research (2019). His current research interests include the discovery of biomarkers and imaging probes, combined with delivery technologies dedicated to cancer and Alzheimer’s disease and has published over 120 publications, including peer-reviewed articles, book chapters, conference abstracts/proceedings, editorials and patents on these subjects. His work is funded by NCI, NIA, NIBIB, DOD, VA grants and ADEKA Corporation.